晚期呈现的结果 阻塞性心下总异常性肺静脉连接-单一体验中心体验中心
Kartik Patel1, Deepti Kakkar1, Himani Pandya2
1Department of Cardio Vascular and Thoracic Surgery, U. N. Mehta Institute of Cardiology and Research Center (affiliated to BJ Medical College, Ahmedabad), Ahmedabad, Gujarat, India.
World journal for pediatric & congenital heart surgery
|January 27, 2025
概括
在患有阻塞性心下全异常肺静脉连接 (TAPVC) 的婴儿中,超过一个月的生存是罕见的. 这项研究确定了这种罕见的儿科心脏病的手术结果的关键风险因素.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 遗传性心脏病是一种先天性心脏病.
- 心脏外科手术 心脏外科手术
背景情况:
- 阻塞性心内全异常肺静脉连接 (TAPVC) 是一种罕见的先天性心脏缺陷.
- 患有这种疾病的婴儿很少活过一个月.
- 关于这种特定患者子组的外科治疗结果的数据有限.
研究的目的:
- 为了确定与患有阻塞性内心TAPVC的婴儿在一个月以上生存的外科手术结果相关的风险因素.
- 为了评估手术干预在这种罕见的儿科心脏病患者群体中的疗效.
主要方法:
- 对14名患有阻塞性心内TAPVC的患者进行了回顾性研究,这些患者的生存时间超过了一个月.
- 数据包括人口统计,手术前实验室,心声图和CT扫描.
- 收集了手术内,手术后和随访临床和心声回声数据.
主要成果:
- 体重低,手术前胆红素升高,使用深度低温循环停止,三腹吐和肺动脉高血压是显著的死亡风险因素.
- 平均随访时间超过6年,大多数患者表现出极好的临床和心声学结果.
- 只有1名患者出现了轻微的无症状流量加速,横跨.
结论:
- 患有阻塞性内心TAPVC的婴儿存活超过一个月,代表了一个罕见但可治疗的队列.
- 及时的手术干预可以带来可接受的早期和优秀的长期结果.
- 识别和管理风险因素对于改善这一群体的外科结果至关重要.
相关概念视频
Cardiac Catheterization II: Right Heart Catheterization
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...


